company

LIA TERAPI AS

2420 TRYSIL

Return on Equity
−0,76 %
Current Ratio
3,33
Debt-to-Equity Ratio
2,76
Key figures (NOK)2022
Revenue4 557 000
Net Income−10 000
Total Assets5 532 000
Total Equity1 323 000
Income (NOK)2022
Revenue4 557 000
Expenditure4 446 000
Operating Profit111 000
Financial Income4 000
Financial Costs122 000
Financial Balance−118 000
Earnings Before Tax−7 000
Tax2 000
Net Income−10 000
Balance (NOK)2022
Total Fixed Assets3 675 000
Total Current Assets1 857 000
Total Assets5 532 000
Total Retained Equity1 223 000
Total Equity1 323 000
Total Long-Term Debt3 650 000
Total Current Debt558 000
Total Equity and Debt5 532 000
Cash flow (NOK)2022
Sales Income0
Other Income4 557 000
Revenue4 557 000
Cost of Goods Sold4 000
Salary Costs2 522 000
Depreciation150 000
Impairment0
Expenditure4 446 000
Operating Profit111 000
Financial Income4 000
Financial Costs122 000
Financial Balance−118 000
Dividends0
Net Income−10 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate3 553 000
Machinery and Plant Facilities0
Fixtures26 000
Total Tangible Assets3 579 000
Total Fiancial Fixed Assets96 000
Total Fixed Assets3 675 000
Stock0
Total Investments0
Cash, Bank1 230 000
Total Current Assets1 857 000
Total Assets5 532 000
Total Equity1 323 000
Short-Term Group Debt0
Total Long-Term Debt3 650 000
Creditors132 000
Unpaid Taxes154 000
Dividends0
Other Current Debt273 000
Total Current Debt558 000
Total Equity and Debt5 532 000
Financial indicators2022
Return on Equity−0,76 %
Debt-to-Equity Ratio2,76
Operating Profit Margin2,44 %
Current Ratio3,33
Quick Ratio3,33
Equity Ratio0,24
Gross Profit Margin99,91 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English